Sodium cyclamate and cyclohexylamine

These substances were identified for action under the Chemicals Management Plan (CMP).

Summary of publications
CAS RN Common name DSL name Draft screening assessment Proposed conclusion on section 64 criteria Follow-up activities
139-05-9 Sodium cyclamate Sulfamic acid, cyclohexyl-, monosodium salt HTML Does not meet Under consideration
108-91-8 Cyclohexylamine (CHA) Cyclohexanamine
Timelines
Date Activity
December 2020 Anticipated publication of the final screening assessment.
December 14, 2019 Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 153, No. 50.

Background

Cyclohexylamine (CAS RN 108-91-8) was identified as being part of the Aliphatic Amines Group at the outset of the third phase of the CMP. This substance was subsequently moved to this assessment of sodium cyclamate, since cyclohexylamine is a metabolite of sodium cyclamate in mammals and cyclohexylamine data were used to assess the risk to human health of both substances.

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: